Could not find the file: /1409/1/Fact Sheet Nr.109_Update.pdf
The file you are trying to access may be related to this item:
Rothschedl, E. and Wolf, S. (2022): Loncastuximab tesirine (Zynlonta®) as monotherapy for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL). Update July 2023. Fact Sheet Nr. 109.
If you reached this page by following a link within the repository, please contact the Repository of AIHTA GmbH administration. Otherwise, please check that you have typed the URL in correctly, or contact the person or site that supplied you with this URL.